Corvus Pharmaceuticals, Inc.
Clinical trials sponsored by Corvus Pharmaceuticals, Inc., explained in plain language.
-
New hope for rare blood cancer: targeted drug soquelitinib faces standard care in phase 3 trial
Disease control Recruiting nowThis study tests a new drug called soquelitinib against standard treatments for people with certain types of T-cell lymphoma that have come back or not responded to therapy. About 150 adults will be randomly assigned to receive either soquelitinib or a standard single-agent chemo…
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new daily pill called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). Researchers want to see if it reduces skin redness, itching, and rash better than a placebo. About 200 participants will take the pill or a dummy pill for 12 weeks…
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC